Erythromycin Gel
Product Images NDC 45802-966

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 45802-966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Erythromycin-topical-gel-carton.jpg (Erythromycin Topical Gel Carton)

Packaging label for Erythromycin Topical Gel USP, 2%, a prescription human drug for dermatologic use only, not for ophthalmic use. The gel has a net weight of 30 g. Label indicates it is distributed by Perrigo and manufactured in Israel by Padagis Israel Pharmaceuticals Ltd. The label includes usage instructions and warnings, and displays the NDC 45802-966-94.*

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of erythromycin showing its macrocyclic lactone ring and attached sugar moieties. The diagram illustrates the molecular components and bonding typical of erythromycin.*

FDA Label Image

Serialization-example (Image 02)

Label panel of Erythromycin 20 mg/g topical gel showing placeholder text fields for serial number, lot number, and expiration date. The label is a simple boxed format with instructions to insert product-specific information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.